Emergent Biosolutions, Inc. has a market cap of $538.7 million; its shares were traded at around $15.41 with a P/E ratio of 13.1 and P/S ratio of 2.
This is the insider trade history vs. stock price of EBS. For the complete insider trading history of EBS, click here.
Directors and Officers Recent Trades:
- Chairman, 10% Owner Fuad El-hibri sold 43,064 shares of EBS stock on 12/04/2012 at the average price of 15.08. Fuad El-hibri owns at least 8,626,553 shares after this. The price of the stock has increased by 2.19% since.
- Chairman, 10% Owner Fuad El-hibri sold 56,936 shares of EBS stock on 12/03/2012 at the average price of 15.14. Fuad El-hibri owns at least 8,669,617 shares after this. The price of the stock has increased by 1.78% since.
- EVP Corporate Svs. Div Robert Kramer sold 28,000 shares of EBS stock on 09/06/2012 at the average price of 14.82. Robert Kramer owns at least 870,173 shares after this. The price of the stock has increased by 3.98% since.
For the complete insider trading history of EBS, click here.





RSS